These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
683 related items for PubMed ID: 30047829
1. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations. Manjula S, Sivanandam M, Kumaradhas P. J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829 [Abstract] [Full Text] [Related]
3. Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598. Xue W, Jiao P, Liu H, Yao X. Antiviral Res; 2014 Apr; 104():40-51. PubMed ID: 24462692 [Abstract] [Full Text] [Related]
6. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. Thueng-in K, Thanongsaksrikul J, Jittavisutthikul S, Seesuay W, Chulanetra M, Sakolvaree Y, Srimanote P, Chaicumpa W. MAbs; 2014 Apr; 6(5):1327-39. PubMed ID: 25517317 [Abstract] [Full Text] [Related]
7. Discovery of novel natural flavonoids as potent antiviral candidates against hepatitis C virus NS5B polymerase. Akher FB, Farrokhzadeh A, Ramharack P, Shunmugam L, Van Heerden FR, Soliman MES. Med Hypotheses; 2019 Nov; 132():109359. PubMed ID: 31466018 [Abstract] [Full Text] [Related]
8. Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors. Yu H, Fang Y, Lu X, Liu Y, Zhang H. Chem Biol Drug Des; 2014 Jan; 83(1):89-105. PubMed ID: 23941500 [Abstract] [Full Text] [Related]
13. Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase. Davis BC, Thorpe IF. Proteins; 2013 Jan 29; 81(1):40-52. PubMed ID: 22855387 [Abstract] [Full Text] [Related]
17. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking. Tarannum H, Nandi S. Comb Chem High Throughput Screen; 2022 Jan 29; 25(4):702-719. PubMed ID: 33475069 [Abstract] [Full Text] [Related]
18. Ligand-induced changes in hepatitis C virus NS5B polymerase structure. Rigat K, Wang Y, Hudyma TW, Ding M, Zheng X, Gentles RG, Beno BR, Gao M, Roberts SB. Antiviral Res; 2010 Nov 29; 88(2):197-206. PubMed ID: 20813137 [Abstract] [Full Text] [Related]
19. Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis. Xue W, Ban Y, Liu H, Yao X. J Chem Inf Model; 2014 Feb 24; 54(2):621-33. PubMed ID: 23745769 [Abstract] [Full Text] [Related]
20. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. Biswal BK, Cherney MM, Wang M, Chan L, Yannopoulos CG, Bilimoria D, Nicolas O, Bedard J, James MN. J Biol Chem; 2005 May 06; 280(18):18202-10. PubMed ID: 15746101 [Abstract] [Full Text] [Related] Page: [Next] [New Search]